Sexual distress among men with cancer – a cross-sectional study
DOI:
https://doi.org/10.2340/1651-226X.2025.42525Keywords:
Sexual ditress, Sexual function, Neoplasms, Health related quality of lifeAbstract
Background and purpose: Many men with cancer experience that changes created by cancer and its treatment may impair sexual function. However, many studies investigating sexual impairments fail to consider whether such impairments are perceived as distressing, i.e. create sexual distress. We investigated the prevalence of sexual distress, overlap with sexual impairment, and sociodemographic and clinical characteristics and other symptoms associated with sexual distress in a heterogeneous male cancer population.
Patients and methods: Across cancer diagnoses, 2792 men in treatment or follow up at the Department of Oncology, Rigshospitalet, were invited. The Sexual Complaint Screener (SCS) assessed sexual impairments and sexual distress. Regression analyses estimated the association of sexual distress with sociodemographic and tumor-related factors, other symptoms (pain, depression, fatigue, insomnia, fear of recurrence), and health-related quality of life. The number of patients who received help for or were interested in a consultation for sexual problems was calculated.
Results: Six hundred and ninety-six patients, most frequently diagnosed with testicular (26%) or multiple (16%) cancers, completed the SCS. Forty-one per cent experienced sexual distress, 60% sexual impairment, and 34% overlapping sexual distress and impairment. Sexual distress was significantly associated with clinically relevant insomnia (OR:2.15; 95% CI:1.5–3.1) and pain (OR:1.90; 95% CI:1.3–2.9). Two thirds of all patients wished for help, but only one third of these were receiving help.
Interpretation: Sexual distress was widespread in men across different cancer diagnoses and sometimes presented without impairment, demonstrating that assessment of sexual problems must include the personal experience of distress and extend to men across cancer diagnoses.
Downloads
References
Lee H, Song M-K. State of the science of sexual health among older cancer survivors: an integrative review. J Cancer Surviv. 2024.
https://doi.org/10.1007/s11764-024-01541-2 DOI: https://doi.org/10.1007/s11764-024-01541-2
Frankland J, Wheelwright S, Permyakova NV, Wright D, Collaço N, Calman L, et al. Prevalence and predictors of poor sexual well-being over 5 years follo wing treatment for colorectal cancer: results from the ColoREctal Well being (CREW) prospective longitudinal study. BMJ Open. 2020;10:e038953.
https://doi.org/10.1136/bmjopen-2020-038953 DOI: https://doi.org/10.1136/bmjopen-2020-038953
Benedict C, Traeger L, Dahn JR, Antoni M, Zhou ES, Bustillo N, et al. Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy. J Sex Med. 2014;11:2571–80.
https://doi.org/10.1111/jsm.12645 DOI: https://doi.org/10.1111/jsm.12645
Cameron S, Springer C, Fox-Wasylyshyn S, El-Masri MM. A descriptive study of functions, symptoms, and perceived health state after radiotherapy for prostate cancer. Eur J Oncol Nurs Off J Eur N Oncol Nurs Soc. 2012;16:310–14.
https://doi.org/10.1016/j.ejon.2011.07.007 DOI: https://doi.org/10.1016/j.ejon.2011.07.007
Reese JB, Handorf E, Haythornthwaite JA. Sexual quality of life, body image distress, and psychosocial outcomes in colorectal cancer: a longitudinal study. Support Care Cancer. 2018;26:3431–40.
https://doi.org/10.1007/s00520-018-4204-3 DOI: https://doi.org/10.1007/s00520-018-4204-3
Bahnsen MK, Graugaard C, Andersson M, Andresen JB, Frisch M. Physical and mental health problems and their associations with inter- personal sexual inactivity and sexual dysfunctions in Denmark: baseline assessment in a national cohort study. J Sex Med. 2022;19:1562–79.
https://doi.org/10.1016/j.jsxm.2022.07.004 DOI: https://doi.org/10.1016/j.jsxm.2022.07.004
Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): initial validation of a stand ardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28:317–30.
https://doi.org/10.1080/00926230290001448 DOI: https://doi.org/10.1080/00926230290001448
Bravi CA, Tin A, Montorsi F, Mulhall JP, Eastham JA, Vickers AJ. Erectile function and sexual satisfaction: the importance of asking about sexual desire. J Sex Med. 2020;17:349–52.
https://doi.org/10.1016/j.jsxm.2019.09.024 DOI: https://doi.org/10.1016/j.jsxm.2019.09.024
Den Oudsten BL, Traa MJ, Thong MSY, Martijn H, De Hingh IHJT, Bosscha K, et al. Higher prevalence of sexual dysfunction in colon and rectal cancer sur vivors compared with the normative population: a population-based study. Eur J Cancer Oxf Engl. 2012;48:3161–70.
https://doi.org/10.1016/j.ejca.2012.04.004 DOI: https://doi.org/10.1016/j.ejca.2012.04.004
Ben Charif A, Bouhnik A-D, Courbière B, Rey D, Préau M, Bendiane M-K, et al. Sexual health problems in French cancer survivors 2 years after diagnosis-the national VICAN survey. J Cancer Surviv Res Pract. 2016;10:600–9.
https://doi.org/10.1007/s11764-015-0506-3 DOI: https://doi.org/10.1007/s11764-015-0506-3
Bond CB, Jensen PT, Groenvold M, Johnsen AT. Prevalence and possible predictors of sexual dysfunction and self-reported needs related to the sexual life of advanced cancer patients. Acta Oncol. 2019;58:769–75.
https://doi.org/10.1080/0284186X.2019.1566774 DOI: https://doi.org/10.1080/0284186X.2019.1566774
Osawa T, Wei JT, Abe T, Honda M, Rew KT, Dunn R, et al. Comparison of health-related quality of life between Japanese and American patients with bladder cancer as measured by a newly developed Japanese version of the bladder cancer index. Bladder Cancer. 2021;7:61–9.
https://doi.org/10.3233/BLC-200359 DOI: https://doi.org/10.3233/BLC-200359
Nørskov KH, Schjoedt I, Tolver A, Jarden M. Sexual health in patients with malignant hematological disease: a Danish cross-sectional study. Sex Med. 2024;12:qfae053.
https://doi.org/10.1093/sexmed/qfae053 DOI: https://doi.org/10.1093/sexmed/qfae053
Gellhaus PT, Cary C, Kaimakliotis HZ, Johnson CS, Weiner M, Koch MO, et al. Long-term health-related quality of life outcomes following radical cystectomy. Urology. 2017;106:82–6.
https://doi.org/10.1016/j.urology.2017.03.053 DOI: https://doi.org/10.1016/j.urology.2017.03.053
Gilbert SM, Dunn RL, Hollenbeck BK, Montie JE, Lee CT, Wood DP, et al. Development and validation of the bladder cancer index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer. J Urol. 2010;183:1764–70.
https://doi.org/10.1016/j.juro.2010.01.013 DOI: https://doi.org/10.1016/j.juro.2010.01.013
Hatzichristou D, Rosen RC, Derogatis LR, Low WY, Meuleman EJH, Sadovsky R, et al. Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med. 2010;7:337–48.
https://doi.org/10.1111/j.1743-6109.2009.01619.x DOI: https://doi.org/10.1111/j.1743-6109.2009.01619.x
Gündüz A, Sertçelik S, Gündoğmuş İ, Zengin Eroğlu M, Kumru Bayazit R, Gönül H, et al. Turkish validity and reliability of the sexual complaints screener for men. Psychiatry Clin Psychopharmacol. 2019;29:597–602.
https://doi.org/10.1080/24750573.2018.1505421 DOI: https://doi.org/10.1080/24750573.2018.1505421
Fugl-Meyer KS, Nilsson M, Hylander B, Lehtihet M. Sexual function and testosterone level in men with conservatively treated chronic kidney disease. Am J Mens Health. 2017;11:1069–76.
https://doi.org/10.1177/1557988317703207 DOI: https://doi.org/10.1177/1557988317703207
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI J Natl Cancer Inst. 1993;85:365–76.
https://doi.org/10.1093/jnci/85.5.365 DOI: https://doi.org/10.1093/jnci/85.5.365
Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of- life scores. J Clin Oncol. 1998;16:139–44.
https://doi.org/10.1200/JCO.1998.16.1.139 DOI: https://doi.org/10.1200/JCO.1998.16.1.139
Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the major depression inventory in measuring severity of depressive states. Psychol Med. 2003;33:351–6.
https://doi.org/10.1017/S0033291702006724 DOI: https://doi.org/10.1017/S0033291702006724
Smets EMA, Garssen B, Bonke B, De Haes JCJM. The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315–25.
https://doi.org/10.1016/0022-3999(94)00125-O DOI: https://doi.org/10.1016/0022-3999(94)00125-O
Thong MSY, Mols F, Poll-Franse LV, Sprangers MAG, Rijt CCD, Barsevick AM, et al. Identifying the subtypes of cancer-related fatigue: results from the p opulation-based PROFILES registry. J Cancer Surviv. 2018;12:38–46.
https://doi.org/10.1007/s11764-017-0641-0 DOI: https://doi.org/10.1007/s11764-017-0641-0
Simard S, Savard J. Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17:241–51.
https://doi.org/10.1007/s00520-008-0444-y DOI: https://doi.org/10.1007/s00520-008-0444-y
Fardell JE, Jones G, Smith AB, Lebel S, Thewes B, Costa D, et al. Exploring the screening capacity of the fear of cancer recurrence inventory-short form for clinical levels of fear of cancer recurrence. Psychooncology. 2018;27:492–9.
https://doi.org/10.1002/pon.4516 DOI: https://doi.org/10.1002/pon.4516
Bastien C. Validation of the insomnia severity index as an outcome measure for in somnia research. Sleep Med. 2001;2:297–307.
https://doi.org/10.1016/S1389-9457(00)00065-4 DOI: https://doi.org/10.1016/S1389-9457(00)00065-4
Savard M-H, Savard J, Simard S, Ivers H. Empirical validation of the insomnia severity index in cancer patients: Insomnia Severity Index and Cancer. Psychooncology. 2005;14:429–41.
https://doi.org/10.1002/pon.860 DOI: https://doi.org/10.1002/pon.860
Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore. 1994;23:129–38.
Shi Q, Mendoza TR, Dueck AC, Ma H, Zhang J, Qian Y, et al. Determination of mild, moderate, and severe pain interference in patients with cancer. Pain. 2017;158:1108–12.
https://doi.org/10.1097/j.pain.0000000000000890 DOI: https://doi.org/10.1097/j.pain.0000000000000890
R: the R project for statistical computing. n.d. [cited 2023 May 11]. Available from: https://www.r-project.org/
Tiruye T, O’Callaghan M, Moretti K, Jay A, Higgs B, Santoro K, et al. Patient-reported functional outcome measures and treatment choice for prostate cancer. BMC Urol. 2022;22:169.
https://doi.org/10.1186/s12894-022-01117-1 DOI: https://doi.org/10.1186/s12894-022-01117-1
Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016;375:1425–37.
https://doi.org/10.1056/NEJMoa1606221 DOI: https://doi.org/10.1056/NEJMoa1606221
Yang L, Lee JA, Heer E, Pernar C, Colditz GA, Pakpahan R, et al. One-year urinary and sexual outcome trajectories among prostate cancer patients treated by radical prostatectomy: a prospective study. BMC Urol. 2021;21:81.
https://doi.org/10.1186/s12894-021-00845-0 DOI: https://doi.org/10.1186/s12894-021-00845-0
Steinsvik EAS, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fosså SD. Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother. BJU Int. 2012;109:1366–74.
https://doi.org/10.1111/j.1464-410X.2011.10598.x DOI: https://doi.org/10.1111/j.1464-410X.2011.10598.x
Downloads
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Jonas Nahavandipour, Christoffer Johansen, Annamaria Giraldi, Bolette Skjøft Rafn, Annika von Heymann
This work is licensed under a Creative Commons Attribution 4.0 International License.
